Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1272099

registered interest
date	17/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to Royal Society of Public Health survey funding that 55 per cent of people in Asian communities would take the covid-19 vaccine, whether he plans to implement public health initiatives for Asian communities to encourage covid-19 vaccine take up.
tabling member constituency	Poplar and Limehouse
tabling member printed	Apsana Begum
uin	131496
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Department, together with the National Health Service (NHS) and Public Health England, is providing advice and information at every opportunity to support uptake in individuals who are prioritised for the COVID-19 vaccine. This includes providing advice to groups who may have questions about the vaccination process, including members from the Asian communities.</p><p>The Department, alongside the Ministry of Housing, Communities and Local Government and NHS England are holding regular meetings with local authorities, faith leaders, and black, Asian and minority ethnic (BAME) organisations to answer questions and provide advice and information about COVID-19 vaccines and how they will be made available.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 16:59:26 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4790 label Biography information for Apsana Begum

1272220

registered interest
date	17/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Kidney Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on the risk of covid-19 transmission for patients with in-centre haemodialysis of those patients being in priority group four for the covid-19 vaccine.
tabling member constituency	Nottingham North
tabling member printed	Alex Norris
uin	131414
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>Of the factors associated with COVID-19 mortality, age is the most strongly associated factor and applies across all other risk factors, including underlying health conditions. There is currently no conclusive evidence to indicate whether COVID-19 vaccines will have an impact on transmission.</p><p>The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed data on the risk of mortality from COVID-19 in-patients receiving in-centre haemodialysis (ICHD). In the ICHD cohort, 30% of all COVID-19 deaths up to 30 June 2020 occurred in persons aged over 80 years old. Those aged over 80 had a mortality risk of about 4.2 times more than those aged 18 to 59 years. Further information is available here: <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241263" target="_blank">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241263</a></p><p>The JCVI has recognised that persons on ICHD attend healthcare facilities regularly, and that this is an opportunity for vaccination. The JCVI therefore agreed that implementation teams should take advantage of this setting to vaccinate eligible individuals.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 131415 question first answered 11/01/2021 15:47:01 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4641 label Biography information for Alex Norris

1272221

registered interest
date	17/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Kidney Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of moving patients with in-centre haemodialysis higher up the priority list for the covid-19 vaccine.
tabling member constituency	Nottingham North
tabling member printed	Alex Norris
uin	131415
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>Of the factors associated with COVID-19 mortality, age is the most strongly associated factor and applies across all other risk factors, including underlying health conditions. There is currently no conclusive evidence to indicate whether COVID-19 vaccines will have an impact on transmission.</p><p>The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed data on the risk of mortality from COVID-19 in-patients receiving in-centre haemodialysis (ICHD). In the ICHD cohort, 30% of all COVID-19 deaths up to 30 June 2020 occurred in persons aged over 80 years old. Those aged over 80 had a mortality risk of about 4.2 times more than those aged 18 to 59 years. Further information is available here: <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241263" target="_blank">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241263</a></p><p>The JCVI has recognised that persons on ICHD attend healthcare facilities regularly, and that this is an opportunity for vaccination. The JCVI therefore agreed that implementation teams should take advantage of this setting to vaccinate eligible individuals.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 131414 question first answered 11/01/2021 15:47:01 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4641 label Biography information for Alex Norris

1272262

registered interest
date	17/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to make covid-19 vaccine information available in Urdu; and where that information can be accessed.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	131474
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Department, together with the National Health Service and Public Health England, are providing advice and information to support the national vaccination programme. The Department, alongside the Ministry of Housing, Communities and Local Government, is holding regular meetings with local authorities, faith leaders, and black, Asian and minority ethnic (BAME) organisations to provide advice and information about COVID-19 vaccines and how they will be made available.</p><p>The communications plan includes targeted information and advice via TV, radio, and social media. This is being translated into 13 languages, including Bengali, Chinese, Filipino, Gujarati, Hindi, Mirpur, Polish, Punjabi and Urdu. Print and online material, including interviews and practical advice will also appear in 600 national, regional, local and specialist titles. Public Health England is also currently developing translated versions of patient advice leaflets in to 19 languages, which will include the following languages: Arabic, Albanian, Chinese, Bengali, French, Farsi, Kurdish, Gujarati, Hindi, Polish, Panjabi, Nepalese, Romanian, Turkish, Tagalog, Spanish, Somali, Ukrainian and Urdu.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 131470 131471 131472 131473 question first answered 11/01/2021 17:07:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1271635

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Buckinghamshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has made for the roll out of the covid-19 vaccine in Buckinghamshire; and what the timetable is for that roll out.
tabling member constituency	Beaconsfield
tabling member printed	Joy Morrissey
uin	130840
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The National Health Service (NHS) has a tried and tested track record for delivering vaccination programmes and is working with existing partners across the healthcare system to ensure the safe and effective deployment of a COVID-19 vaccine across every region of the United Kingdom.</p><p>Alongside local partners, the NHS has been working to ensure fair access and maximum uptake of the vaccine which is why it has developed three different models of delivery. Included in this are hospital hubs, local vaccination services and vaccination centres. More than 730 vaccination sites have already been established across the UK and hundreds more are opening shortly to take the total to over 1,000.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 16:41:35 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4759 label Biography information for Joy Morrissey

1271667

registered interest
date	16/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Life Sciences and Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans he has to direct funds within the £11.1 billion in R&D funding announced in the Spending Review 2020 to programmes that support (a) health research and (b) life sciences R&D and deliver high-value jobs and investment to towns and cities in the North of England.
tabling member constituency	Rother Valley
tabling member printed	Alexander Stafford
uin	130882
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Department’s Research and Development (R&amp;D) Spending Review 2020 settlement supports our Departmental commitments as set out in the R&amp;D Roadmap and helps to consolidate the UK’s position as a science superpower.</p><p> </p><p>Indeed, the UK has one of the strongest and most productive life sciences sectors in the world, generating turnover of around £80.7 billion per annum in 2019.</p><p> </p><p>Funding is subject to the departmental allocations process which is now underway. Further details of how funding will be allocated will be announced in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 15:26:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4866 label Biography information for Alexander Stafford

1271700

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether community nurses working with patients who have tested positive for covid-19 will be given the same priority and access to the covid-19 vaccination as nurses working in a hospital setting.
tabling member constituency	Canterbury
tabling member printed	Rosie Duffield
uin	130802
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who advise the Government on which vaccine/s the United Kingdom should use, including prioritisation at a population level. For the first phase, the JVCI has advised that the vaccine be given to care home residents and staff, as well as frontline health and social care workers, then to the rest of the population in order of age and clinical risk factors.</p><p> </p><p>The JCVI considers frontline health and social care workers who provide care to vulnerable people a high priority for vaccination. The definition of frontline healthcare staff includes those involved in direct patient care. This includes staff who have frequent face-to-face clinical contact with patients and who are directly involved in patient care in either secondary or primary care/community settings.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 126773 question first answered 11/01/2021 16:02:03 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4616 label Biography information for Rosie Duffield

1271720

registered interest
date	16/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Wind Power: Seas and Oceans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to his Department's publication entitled Steel public procurement 2020: Compliance with the steel procurement guidance (PPN 11/16), published 09 October 2020, if he will make it his policy to include figures on the share of steel produced in the UK that is used in offshore wind developments that are supported by the public purse in future editions of that publication.
tabling member constituency	Ogmore
tabling member printed	Chris Elmore
uin	130798
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Government is committed to ensuring that UK steel producers have the best possible chance of competing for and winning the contracts associated with our domestic infrastructure investment.</p><p> </p><p>The publication of the annual steel pipeline on national infrastructure projects and steel data on public sector procurement is part of this commitment. This information serves both as testament to our ambitious plans for the use of UK-sourced steel within our pipeline of major public infrastructure projects, but also as an accountability mechanism, as we work in collaboration with the sector to achieve this shared aim.</p><p> </p><p>In October 2020 we published data of the steel pipeline of offshore wind national infrastructure projects to enable UK steel manufacturers to better plan for these projects.</p><p> </p><p>Going forward, the Government will consider whether to publish annual figures of UK steel used in past offshore wind projects, if it is in the public interest.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 15:22:38 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4572 label Biography information for Chris Elmore

1271832

registered interest
date	16/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the cost to the public purse of the Pfizer covid-19 vaccine to date; and when he plan to publish details of the estimated cost to all stakeholders for the manufacturing and rollout of that vaccine.
tabling member constituency	Tatton
tabling member printed	Esther McVey
uin	130712
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>We are not able to disclose details of commercially sensitive contracts between the Government and vaccine manufacturers while negotiations are ongoing.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 14:34:46 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4084 label Biography information for Esther McVey

1271833

registered interest
date	16/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps were taken during the trial of the Pfizer covid-19 vaccine to test its effect on people with allergies.
tabling member constituency	Tatton
tabling member printed	Esther McVey
uin	130713
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Pfizer/BioNTech vaccine has met the Medicines and Healthcare products Regulatory Agency’s robust standards of safety, quality, and effectiveness, and the safety data from the trials has set out how the COVID-19 vaccine works in different types of people. A robust and proactive safety monitoring strategy for COVID-19 vaccines is in place, which allows for rapid, real-time safety monitoring at population level.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 14:33:24 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4084 label Biography information for Esther McVey